To prospectively observe the long-term antiviral efficacy and safety of telbivudine ( LDT ) administered as a monotherapy and as a combination therapy with adefovir dipivoxil ( ADV ) in patients diagnosed with chronic hepatitis B ( CHB ) and positivity for hepatitis B e antigen ( HBeAg ) .